Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;46(6):1023-1035.
doi: 10.1111/acer.14838. Epub 2022 May 2.

COVID-19 patients with documented alcohol use disorder or alcohol-related complications are more likely to be hospitalized and have higher all-cause mortality

Affiliations

COVID-19 patients with documented alcohol use disorder or alcohol-related complications are more likely to be hospitalized and have higher all-cause mortality

Kristina L Bailey et al. Alcohol Clin Exp Res. 2022 Jun.

Abstract

Background: Coronavirus Disease 2019 (COVID-19) has affected every country globally, with hundreds of millions of people infected with the SARS-CoV-2 virus and over 6 million deaths to date. It is unknown how alcohol use disorder (AUD) affects the severity and mortality of COVID-19. AUD is known to increase the severity and mortality of bacterial pneumonia and the risk of developing acute respiratory distress syndrome. Our objective is to determine whether individuals with AUD have increased severity and mortality from COVID-19.

Methods: We utilized a retrospective cohort study of inpatients and outpatients from 44 centers participating in the National COVID Cohort Collaborative. All were adult COVID-19 patients with and without documented AUDs.

Results: We identified 25,583 COVID-19 patients with an AUD and 1,309,445 without. In unadjusted comparisons, those with AUD had higher odds of hospitalization (odds ratio [OR] 2.00, 95% confidence interval [CI] 1.94 to 2.06, p < 0.001). After adjustment for age, sex, race/ethnicity, smoking, body mass index, and comorbidities, individuals with an AUD still had higher odds of requiring hospitalization (adjusted OR [aOR] 1.51, CI 1.46 to 1.56, p < 0.001). In unadjusted comparisons, individuals with AUD had higher odds of all-cause mortality (OR 2.18, CI 2.05 to 2.31, p < 0.001). After adjustment as above, individuals with an AUD still had higher odds of all-cause mortality (aOR 1.55, CI 1.46 to 1.65, p < 0.001).

Conclusion: This work suggests that AUD can increase the severity and mortality of COVID-19 infection. This reinforces the need for clinicians to obtain an accurate alcohol history from patients hospitalized with COVID-19. For this study, our results are limited by an inability to quantify the daily drinking habits of the participants. Studies are needed to determine the mechanisms by which AUD increases the severity and mortality of COVID-19.

Keywords: ARDS; EtOH; SARS-CoV-2; alcoholic; smoking; viral pneumonia.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Summary of the analysis strategy. AUD, alcohol use disorder; BMI, body mass index; ED, emergency department
FIGURE 2
FIGURE 2
Geographic distribution of the cohort

References

    1. Bailey, K.L. , Romberger, D.J. , Katafiasz, D.M. , Heires, A.J. , Sisson, J.H. , Wyatt, T.A. et al. (2015) TLR 2 and TLR 4 expression and inflammatory cytokines are altered in the airway epithelium of those with alcohol use disorders. Alcoholism: Clinical and Experimental Research, 39, 1691–1697. - PMC - PubMed
    1. Bailey, K.L. , Samuelson, D.R. & Wyatt, T.A. (2021) Alcohol use disorder: a pre‐existing condition for COVID‐19? Alcohol, 90, 11–17. - PMC - PubMed
    1. Bailey, K.L. , Wyatt, T.A. , Katafiasz, D.M. , Taylor, K.W. , Heires, A.J. , Sisson, J.H. et al. (2019) Alcohol and cannabis use alter pulmonary innate immunity. Alcohol, 80, 131–138. - PMC - PubMed
    1. Bajaj, J.S. , Garcia‐Tsao, G. , Biggins, S.W. , Kamath, P.S. , Wong, F. , McGeorge, S. et al. (2021) Comparison of mortality risk in patients with cirrhosis and COVID‐19 compared with patients with cirrhosis alone and COVID‐19 alone: multicentre matched cohort. Gut, 70, 531–536. - PMC - PubMed
    1. Barron, E. , Bakhai, C. , Kar, P. , Weaver, A. , Bradley, D. , Ismail, H. et al. (2020) Associations of type 1 and type 2 diabetes with COVID‐19‐related mortality in England: a whole‐population study. The Lancet Diabetes & Endocrinology, 8, 813–822. - PMC - PubMed

Publication types